Canopy Growth Corporation Stock Nasdaq

Equities

CGC

CA1380357048

Pharmaceuticals

Market Closed - Nasdaq 04:15:00 2024-05-03 pm EDT 5-day change 1st Jan Change
10.24 USD -0.97% Intraday chart for Canopy Growth Corporation +14.93% +100.39%
Sales 2024 * 320M 234M Sales 2025 * 302M 221M Capitalization 1.05B 764M
Net income 2024 * -491M -359M Net income 2025 * -121M -88.35M EV / Sales 2024 * 4.6 x
Net Debt 2024 * 427M 312M Net Debt 2025 * 403M 294M EV / Sales 2025 * 4.8 x
P/E ratio 2024 *
-2.39 x
P/E ratio 2025 *
-10.4 x
Employees 1,621
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.97%
1 week+14.93%
Current month-31.18%
1 month+4.70%
3 months+120.69%
6 months+63.06%
Current year+100.39%
More quotes
1 week
8.10
Extreme 8.1
14.92
1 month
6.09
Extreme 6.09
14.92
Current year
2.76
Extreme 2.755
14.92
1 year
2.76
Extreme 2.755
19.20
3 years
2.76
Extreme 2.755
269.60
5 years
2.76
Extreme 2.755
564.97
10 years
2.76
Extreme 2.755
592.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 18-10-31
Director of Finance/CFO 52 19-12-01
Investor Relations Contact - 15-12-31
Members of the board TitleAgeSince
Chief Executive Officer 60 18-10-31
Chairman 69 20-03-30
Director/Board Member 67 20-03-30
More insiders
Date Price Change Volume
24-05-03 10.24 -0.97% 15,724,844
24-05-02 10.34 -9.62% 29,703,467
24-05-01 11.44 -23.12% 55,264,353
24-04-30 14.88 +78.85% 83,576,929
24-04-29 8.32 -6.62% 10,137,150

Delayed Quote Nasdaq, May 03, 2024 at 04:15 pm EDT

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
13.94 CAD
Average target price
6.155 CAD
Spread / Average Target
-55.85%
Consensus